Resultados de la búsqueda 1-10 of 11151 for Parkinson's disease
... Parkinson and Movement Disorder Society Task Force on Early-Onset Parkinson's Disease. Movement Disorders Clinical Practice. 2022; doi:10.1002/mdc3.13523 ...
This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...
Accessed April 8, 2024. Hauser RA, et al. Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease. Parkinsonism and Related ...
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...
Connect with others like you for support and answers to your questions in the Parkinson's Disease support group on Mayo Clinic Connect, a patient community.
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic ...
... Parkinson's disease, dementia, chronic pain, brain disease that results from liver disease and other conditions. Riesgos. MEG does not use any magnets ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?